Monday, June 30, 2014

10 Best Healthcare Equipment Stocks To Own Right Now

From the Editor: Shah Gilani is one of the few people who can show you how it really is. In this case, he's going to show you the real reason the Fed chose not to taper. If you're overly idealistic, don't read this. It will only anger you. That, of course, is why Shah's naming names today...

Ben Bernanke is the don of the greatest criminal enterprise in the world.

And yesterday his made monsters, the Five Families, lined up to kiss his ring, again.

By not "tapering" or reducing the $85 billion a month ($45 billion in Treasuries and $40 billion in agency mortgage-backed securities) the Fed is buying from banks, the Fed is saying to its hit men, "We are family, and as long as Johnny Law is coming after you, we've got your back."

The "legal and litigation costs" (that means lawyers and fines) racked up by America's Five Families since the credit crisis gently (not) ushered in the Great Recession is over $103 billion, by some estimates. That doesn't include actual losses from related activities.

Top Financial Stocks To Buy Right Now: TotalFinaElf S.A.(TOT)

TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.

Advisors' Opinion:
  • [By Arjun Sreekumar]

    Refining weakness common among oil majors
    Shell is not the only oil major suffering from an underperforming downstream segment. In fact, all of its peers, including Total (NYSE: TOT  ) , ExxonMobil (NYSE: XOM  ) , Chevron (NYSE: CVX  ) , and BP (NYSE: BP  ) , blamed weak refining margins for disappointing financial performances last year. Exxon's fourth-quarter downstream earnings plunged by $852�million�to $916�million, while Chevron's international downstream earnings plunged by nearly 80% to $125�million.

10 Best Healthcare Equipment Stocks To Own Right Now: TASER International Inc.(TASR)

TASER International, Inc. develops, manufactures, and sells electronic control devices (ECD) for use in the law enforcement, military, corrections, private security, and personal defense markets. ECDs transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. Its products for the law enforcement, military, corrections, and professional security market include the TASER X26 product line, which consists of TASER X26, various cartridges, a digital power magazine, data download software and equipment, extended warranties, and a range of holstering options and accessories; TASER X3, a multi-shot ECD that would engage three separate targets; and ADVANCED TASER M26 product line comprising the ADVANCED TASER M26, various cartridges, rechargeable batteries, a battery charging system, data download software and equipment, extended warranties, and various holstering options and accessories. The company also provides TASER XREP, a self-contained, wireless ECD that deploys from a 12-gauge pump-action shotgun; and TASER Shockwave security system for safety and stand-off capability during hostile situations. In addition, it manufactures TASER C2, TASER X26C, and ADVANCED TASER M26C devices for the personal defense market, as well as provides various cartridges and other accessories. The company sells its products worldwide through its direct sales force, distribution partners, online store, and third-party resellers. TASER International, Inc. was founded in 1993 and is headquartered in Scottsdale, Arizona.

Advisors' Opinion:
  • [By James E. Brumley]

    On the surface, the press release in and of itself may seem benign ... almost innocuous. When you start to proverbially put two and two together, however, this morning's news from View Systems Inc. (OTCBB:VSYM) could actually be early notice that things are about to change for the young, small company. By digging deeper into the details, it becomes clear that VSYM could become in Brazil what TASER International, Inc. (NASDAQ:TASR) and OSI Systems, Inc. (NASDAQ:OSIS) have become in the United States - security icons. View Systems shareholders could be on the same bullish receiving end of things that OSIS and TASR shareholders were on when each of those companies were experiencing a growth spurt a few years back.

  • [By Louis Navellier]

    Another stock that has had a great year in 2013 is Taser (TASR). The company has seen strong order flow from military and police customers this year, and sales and earnings have just exploded along with TASR stock price. TASR stock price has doubled, but the earnings have more than tripled so far in 2013. Business has improved so rapidly that analysts have been caught flatfooted, and the company has posted three consecutive positive earnings surprises. The company is also seeing strong orders from police departments around the country for the new wearable cameras that have helped curb complaints and resolve accusations of bad behavior by officers. The stock is rated “B” by Portfolio Grader and remains a “buy.”

  • [By Rich Smith]

    In its latest update on stun-gun sales, TASER International (NASDAQ: TASR  ) reported Monday that it's booked several new orders for its eponymous stunguns. All are expected to ship and to show up in Q2 earnings when the company releases those in July. Specifically, Taser has sold:

  • [By Dan Caplinger]

    At least for now, competition doesn't seem to be weighing against Smith & Wesson. TASER (NASDAQ: TASR  ) has seen a ramp-up in growth prospects, but it's drawing at least as much of its business from law enforcement and other government purchases rather than private sales. An interesting competitive threat comes from the potential to use 3-D printers to produce firearms, but with the State Department having clamped down on one such gun maker, such efforts won't be large enough in scale for the foreseeable future.

10 Best Healthcare Equipment Stocks To Own Right Now: ITT Educational Services Inc (ESI)

ITT Educational Services, Inc. (ITT/ESI), incorporated in 1946, is a provider of postsecondary degree programs in the United States. As of December 31, 2011, the Company offered master, bachelor and associate degree programs to approximately 73,000 students. As of December 31, 2011, the Company had 144 locations (including 141 campuses and three learning sites) in 39 states. In addition, ITT/ESI offered one or more of its online programs to students who were located in 48 states. The Company designs its education programs, after consultation with employers and other constituents, to help graduates prepare for careers in various fields involving their areas of study. The Company provides career-oriented education programs under the Daniel Webster College (DWC) name. During the year ended December 31, 2011, it began operations at 11 new ITT Technical Institute campuses and discontinued operations at one learning site. As of December 31, 2011, the ITT Technical Institutes offered 55 degree programs in various fields of study across the schools of study, such as information technology (IT); electronics technology; drafting and design; business; criminal justice, and breckinridge school of nursing and health sciences. As of December 31, 2011, the Company had 144 locations (including 141 campuses and three learning sites) in 39 states, which provided postsecondary education to approximately 73,000 students. In 2011, the Company derived approximately 98% of its revenue from tuition and approximately 2% from the sale of tool kits and fees, charged to and paid by, or on behalf of, its students. On August 1, 2013, the Company announced that it has acquired Cable Holdings, LLC.

At most of its campuses, ITT/ESI organizes the academic schedule for programs of study on the basis of four 12-week academic quarters in a calendar year, with new students beginning at the start of each academic quarter. At these campuses, students taking a full-time course load can complete its associate degree programs in ! eight academic quarters, bachelor degree programs in 14 or 15 academic quarters and a master degree program in six or seven academic quarters. ITT/ESI offers classes in residence programs in 3.5- to 5.5-hour sessions three days a week, Monday through Saturday, with all program courses taught entirely or partially in residence; or sessions that are scheduled two to three days a week, Monday through Saturday, with certain program courses taught entirely or partially online over the Internet academic quarters. Depending on student enrollment, class sessions at the most of its campuses are available in the morning, afternoon and evening. The courses that are taught online over the Internet are delivered through an asynchronous learning network and have a prescribed schedule for completion of the coursework. In addition to courses directly related to a student�� program of study, its programs also include general education courses in the humanities, composition, mathematics, the sciences and the social sciences.

Advisors' Opinion:
  • [By Sally Jones]

    Both CSP Inc. (CPSI) and ITT Educational Services Inc. (ESI) have struggled in the last year. Their revenues are way down as of the second quarter, year over year. Richard Blum�� Blum Capital Partners LP continues to trim sinking education companies where the company is 10% owner, and John Rogers of Ariel Capital Management cuts a long-held defense company that delivered high gains over five years.

  • [By Geoff Gannon]

    A German blogger just posted about this site. It is a list of the most shorted stocks in the USA...
    I was surprised that ITT Educational (ESI), Carbo Ceramics (CRR), and Boston Beer (SAM) are on this list...

  • [By Rich Smith]

    This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a downgrade for ITT Educational (NYSE: ESI  ) , an upgrade for Facebook (NASDAQ: FB  ) , and a much improved price target for tiny iRobot (NASDAQ: IRBT  ) . Let's dive right in, beginning with why one analyst just...

  • [By Ben Levisohn]

    Last week, ITT Educational Services (ESI) filed an 8-K disclosing that it was being investigated by the Consumer Financial Protection Bureau to determine whether it broke any rules in how it marketed loans.

    Reuters

    The filing, however, hasn’t had much of an impact. Shares of ITT Educational Services have dropped just 3.4% this week but have gained 95% so far in 2013. Corinthian Colleges (COCO), on the other hand, has dropped 27% this year, while DeVry Education (DV) has gained 50% and Apollo Education (APOL) has advanced 30%.

    So why don’t investors care about the announcement? First of all, investors have known this was coming. Second, no one believes it will result in a damaging fine. William Blair’s Timo Connor explains:

    We view as unlikely a severely punitive settlement against ITT Education from the Consumer Financial Protection Bureau (CFPB) related to its continuing investigation of marketing practices on third-party student lending programs, and we believe the risk is a manageable one for ITT. We continue to like the company�� competitive positioning in capacity-constrained, growing educational markets like drafting, electronics, IT, and nursing, and believe the stock will distance itself from legacy student loan issues in the coming years…

    Connor‘s optimism also stems from previous penalties assessed by the CFPB: The median fine has been $3.9 million, or just 0.4% of ITT Educational Services market cap, Connor says.

    Shares of ITT Educational Services have gained 1.8% to $33.87 today at 1:09 p.m., while Corinthian Colleges has risen 1.7% to $1.79, DeVry Education advanced 0.6% to $35.48 and Apollo Education has ticked down 0.1% to $27.17.

10 Best Healthcare Equipment Stocks To Own Right Now: IDEXX Laboratories Inc (IDXX)

IDEXX Laboratories, Inc., incorporated in 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.

The Company sells a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its primary products and services are point-of-care veterinary diagnostic products, consisting of instruments and consumables and rapid assays; veterinary reference laboratory diagnostic and consulting services used by veterinarians; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; practice management systems and services and digital radiography systems used by veterinarians; products that test milk for antibiotic residues and other contaminants, and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market.

Companion Animal Group

The Company markets a range of in-clinic laboratory analyzers for use in providing reference laboratory quality diagnostic results in companion animal veterinary practices, which it refers ! to as the IDEXX VetLab suite of analyzers. The Company sells two chemistry analyzers, the Catalyst Dx Chemistry Analyzer and the VetTest Chemistry Analyzer, that are used by veterinarians to measure levels of certain enzymes and other substances in blood or urine for monitoring health status and assistance in diagnosing physiologic conditions. Both instruments use consumables manufactured for IDEXX by Ortho-Clinical Diagnostics, Inc. (Ortho), a subsidiary of Johnson & Johnson, based on Ortho�� dry slide technology (Catalyst Dx slides, VetTest slides or slides). In addition, the Catalyst Dx analyzer also uses dry slide electrolyte consumables manufactured by IDEXX at OPTI Medical Systems, one of its wholly owned subsidiaries. Blood tests commonly run on these analyzers include glucose, alkaline phosphatase, alanine aminotransferase (ALT), albumin, creatinine, blood urea nitrogen (BUN), and total protein. Tests are sold individually and in prepackaged panels. Both analyzers also run a urine test called urine protein:creatinine ratio, which assists in the detection of early renal disease.

The Catalyst Dx analyzer is the Company�� chemistry analyzer. The Catalyst Dx analyzer allows a veterinarian to run multiple patient samples simultaneously; to run different sample types, including whole blood, plasma, serum and urine; to perform 28 different chemistry and electrolyte tests; and to automatically calculate other parameters and ratios important to blood chemistry analysis. Its VetLyte Electrolyte Analyzer measures three electrolytes-sodium, potassium and chloride-to aid in evaluating acid-base and electrolyte balances and assessing plasma hydration. Its VetStat Electrolyte and Blood Gas Analyzer measures electrolytes, blood gases, glucose and ionized calcium, and calculates other parameters, such as base excess and anion gap. These measurements aid veterinarians in diagnosing various disease states, evaluating fluid therapy choices and measuring respiratory function. The VetStat analyzer ru! ns single! -use disposable cassettes that contain various configurations of analytes. The VetStat analyzer and its cassettes are manufactured by OPTI Medical Systems.

The Company sells three hematology analyzers that assess the cellular components of blood, including red blood cells, white blood cells and platelets (also called a complete blood count (CBC)). These analyzers include the ProCyte Dx Hematology Analyzer, which uses laser-flow cytometry, optical fluorescence and laminar-flow impedance in its analysis; the LaserCyte Hematology Analyzer, which uses laser-flow cytometry technology in its analysis, and the IDEXX VetAutoread Hematology Analyzer. It also sells the Coag Dx Analyzer, which permits the detection and diagnosis of blood clotting disorders. The ProCyte Dx analyzer provides validated results for five species (canine, feline, equine, bovine and ferret) for up to 24 different blood parameters, providing a more complete picture of each patient�� health.

The SNAPshot Dx analyzer provides quantitative measurements of total thyroxine (T4), cortisol and bile acids to assist in the evaluation of thyroid, adrenal and liver function. The SNAPshot Dx analyzer also reads, interprets and records the results of many IDEXX rapid assay SNAP tests, including its canine SNAP 4Dx test, feline SNAP FIV/FeLV Combo test, canine SNAP cPL test, feline SNAP fPL test, SNAP Feline Triple test and canine SNAP Heartworm RT test. The IDEXX VetLab UA Analyzer provides chemical urinalysis and is validated specifically for veterinary use. The IDEXX VetLab Station (IVLS) connects and integrates the diagnostic information from all the IDEXX VetLab equipment and thus provides reference laboratory information management system capability. It sells the IVLS as an integral component of the Catalyst Dx, LaserCyte and ProCyte Dx analyzers and also as a standalone hardware platform.

The IVLS includes a user interface to input patient information, connect with a practice management system and send i! nformatio! n to run the individual analyzers. IVLS also generates one integrated patient report incorporating all of the lab work generated by the IDEXX VetLab suite; stores, retrieves and analyzes historical patient diagnostics data, including SNAP test results; and sends and receives information from practice management systems, including the IDEXX Cornerstone system, as well as a variety of third-party systems. It sells a range of single-use, handheld test kits under the SNAP name. In addition to its single-use tests, it sells a range of microwell-based test kits under the PetChek name for canine heartworm, FIV and FeLV.

The Company offers commercial reference laboratory diagnostic and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, South Africa, China and South Korea and to bioresearch customers in the United States and Europe. The Company provides specialized veterinary consultation, telemedicine and advisory services, including radiology, cardiology, internal medicine and ultrasound consulting. It develops, markets and sells practice management systems, including hardware and software, and services that run certain functions of veterinary clinics, including managing patient electronic health records, scheduling (including boarding and grooming), reminders, billing and inventory management.

The Company markets and sells two digital radiography systems for use in the small animal veterinary hospital: the IDEXX-DR 1417 and the IDEXX I-Vision CR. Its digital radiography systems use IDEXX-PACS and IDEXX EquiView PACS picture archiving and communication system (PACS) software for the viewing, manipulation, management, storage and retrieval of the digital images generated by the digital capture plate. In September 2011, the Company launched IDEXX I-Vision Mobile, an application that allows veterinarians with the IDEXX-DR 1417 and IDEXX I-Vision CR systems, as well as its digital radiography systems, to request, view and send images using an iPa! d or an A! ndroid mobile tablet. This application integrates with its IDEXX-PACS software.

Water

The Company offers a range of products used in the detection and quantification of various microbiological parameters in water. Its principal products are the Colilert, Colilert-18 and Colisure tests, which simultaneously detect the presence of total coliforms and E. coli in water. These organisms are used as indicators of microbial contamination in water. These products utilize indicator-nutrients that produce a change in color or fluorescence when metabolized by target microbes in the sample. Its water tests are used by government laboratories, water utilities and private certified laboratories to test drinking water. The tests also are used in evaluating water used in production processes (for example, in beverage and pharmaceutical applications) and in evaluating bottled water, recreational water, waste water and water from private wells.

Livestock and Poultry Diagnostics

The Company sells diagnostic tests and related instrumentation that are used to detect a range of diseases and to monitor health status in livestock and poultry. Its livestock and poultry diagnostic products are purchased by government and private laboratories that provide testing services to cattle, swine and poultry veterinarians and producers. Its principal products include tests for Bovine Viral Diarrhea Virus (BVDV), Porcine Reproductive and Respiratory Syndrome (PRRS) and Bovine Spongiform Encephalopathy (BSE or mad cow disease). BVDV is a common and contagious viral infection that suppresses the immune system, making the animal susceptible to a host of other infections, impacting beef and dairy production yields as a result. PRRS is a contagious virus causing reproductive problems and respiratory diseases. BSE is a fatal neurodegenerative disease in cattle that causes a spongy degeneration in the brain and spinal cord.

Other

The principal products in the Company�! � Dairy ! business are its SNAP tests used to detect antibiotic drug-residue in milk. Its primary product line for detecting antibiotic residue in milk is SNAP Beta-Lactam, which detects penicillin, amoxicillin, ceftiofur and cephaphirin residues, followed by SNAPduo Beta-Tetra, which detects certain tetracycline antibiotic residues in addition to those detected by the SNAP Beta Lactam test kits. It also sells SNAP tests for the detection of certain other contaminants in milk, such as chemical melamine and Alfatoxin M1.

The Company sells OPTI point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, BUN and ionized calcium, and to calculate other parameters, such as base excess and anion gap. These analyzers are used primarily in emergency rooms, operating rooms, cardiac monitoring areas and other locations where time-critical diagnostic testing is performed within the hospital setting. The OPTI CCA and OPTI Touch Electrolyte and Blood Gas Analyzers run single-use disposable cassettes that contain various configurations of analytes; the OPTI R Analyzer runs reusable cassettes in various analyte configurations; and the OPTI LION Stat Electrolyte Analyzer runs single-use electrolyte cassettes. OPTI Medical Systems also manufactures its VetStat analyzer and provides the electrolyte module and dry slide reagents that make up the electrolyte testing functionality of the Catalyst Dx analyzer.

The Company competes with VCA Antech, Inc., Abaxis, Inc., Butler, Radiometer A/S, Siemens Medical Solutions Diagnostics, Instrumentation Laboratory, Abbott Diagnostics and Roche Diagnostics.

Advisors' Opinion:
  • [By Tim Brugger]

    After 10 years on the board of IDEXX Laboratories (NASDAQ: IDXX  ) , including serving on its audit and compensation committees, Brian McKeon has been named IDEXX's new executive vice president and CFO, the company announced today. McKeon's appointment as CFO becomes effective Jan. 1, though he has resigned from the IDEXX board as of Oct. 11, the company said.

10 Best Healthcare Equipment Stocks To Own Right Now: Home Bancorp Inc.(HBCP)

Home Bancorp, Inc. operates as the holding company for Home Bank that provides various banking services in Louisiana. The company offers various deposit products, including interest-bearing and noninterest-bearing checking, money market, savings, and negotiable order of withdrawal accounts; and demand deposit and certificates of deposit. It also provides various loan products, such as single-family residential first mortgage loans, commercial real estate mortgage loans, commercial loans, home equity loans and lines of credit, construction and land loans, and other loans. In addition, the company offers online banking, bank cards, and ATM services. As of December 31, 2010, it had 18 full-service banking offices in the Greater Lafayette, Baton Rouge, and Northshore regions of south Louisiana. The company was founded in 1908 and is headquartered in Lafayette, Louisiana.

Advisors' Opinion:
  • [By Tim Melvin]

    The credit crisis slowed the pace of deals temporarily, but there are plenty of former thrifts trading at low valuations that have the potential for large long-term returns.

    Home Bancorp (HBCP)

    Home Bancorp (HBCP) is a 22-branch bank located in Lafayette, La. The bank has almost $1 billion in assets and the balance sheet is in excellent condition. Also, its equity-to-asset ratio is 14.5 — well above my preferred minimum of 10. Meanwhile, Home Bancorp’s nonperforming assets are just 2.09% of the total.

10 Best Healthcare Equipment Stocks To Own Right Now: Chart Industries Inc (GTLS)

Chart Industries, Inc., incorporated on June 25, 1992, is an independent global manufacturer of engineered equipment used in the production, storage and end-use of hydrocarbon and industrial gases. The Company supplies engineered equipment used throughout the global liquid gas supply chain. It operates in three segments: energy and chemicals (E&C), distribution and storage or (D&S), and biomedical. The E&C and D&S segments manufacture products used primarily in energy-related and general industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. Through its BioMedical segment, it supplies cryogenic and other equipment used in the storage and distribution of biological materials and oxygen, used primarily in the medical, biological research and animal breeding industries.

The Company�� products, including vacuum insulated containment vessels, heat exchangers, cold boxes and other cryogenic components, are used throughout the liquid gas supply chain for the purification, liquefaction, distribution, storage and end-use of hydrocarbon and industrial gases. It is a manufacturer of standard and engineered equipment primarily used for low-temperature and cryogenic applications. The Company�� primary customers are multinational producers and distributors of hydrocarbon and industrial gases and their suppliers. The Company sells its products and services to more than 2,000 customers worldwide.

Energy and Chemicals Segment

The Company is a designer and manufacturer of cryogenic brazed aluminum and air cooled heat exchangers. The Company�� brazed aluminum heat exchangers are incorporated into assemblies and cold boxes to facilitate the progressive cooling and liquefaction of air or hydrocarbon mixtures for the subsequent recovery or purification of component gases. In hydrocarbon processing industries, its brazed aluminum heat exchangers allow producers to obtain purified hydrocarbon by-products, such ! as methane, ethane, propane and ethylene, which are commercially marketable for various industrial or residential uses. In the industrial gas market, its brazed aluminum heat exchangers are used to produce high purity atmospheric gases, such as oxygen, nitrogen and argon, which have diverse industrial applications. The Company�� air cooled heat exchangers are used in multiple markets to cool fluids to allow for further processing or to provide condensing of fluids, including hydrocarbon, petrochemical, natural gas processing, and power generation. Its compact Core-in-Kettle heat exchangers are designed to replace shell-and-tube exchangers, offering significantly more heat transfer surface per unit volume and improving the efficiency of chillers, vaporizers, reboilers and condensers in hydrocarbon applications including ethylene, propylene and LNG.

The Company is a designer and fabricator of cold boxes. Cold boxes are engineered systems used to reduce the temperature of gas mixtures to the point where component gases liquefy and can be separated and purified for further use in multiple industrial, scientific and commercial applications. In the hydrocarbon processing industry, its cold box systems are used in natural gas processing and in the petrochemical industry. In the industrial gas industry, cold box systems are used to separate air into its atmospheric components, including nitrogen, oxygen and argon, where the gases are used in a diverse range of applications, such as metal production and heat treating, enhanced oil and gas production, coal gasification, chemical and oil refining, the quick-freezing of food, wastewater treatment and industrial welding. The construction of a cold box system generally consists of one or more brazed aluminum heat exchangers and other equipment packaged in a box consisting of a structural metal frame encasing a complex system of piping, valves and instrumentation.

The Company designs and manufactures of engineered hydrocarbon process syst! ems speci! fically for those markets requiring cryogenic processing technology. These Concept-to-Reality process systems incorporate many of Chart�� core products, including brazed aluminum heat exchangers, Core-in-Kettles, cold boxes, vessels, pipe work and air cooled heat exchangers. These systems are used for global LNG projects, including projects in the United States and China for both domestic LNG production for diesel displacement and in the conversion of LNG import terminals to export terminals, and also for use in global nitrogen rejection units (NRU) and propane dehydrogenation (PDH).

Distribution and Storage Segment

The Company is a supplier of cryogenic equipment to the global bulk and packaged industrial gas industry as well as for energy-related applications. Its products span the entire spectrum of industrial gas demand from small customers requiring cryogenic packaged gases to large users requiring custom engineered cryogenic storage systems. Its products in the D&S segment include Cryogenic Bulk Storage Systems, Cryogenic Packaged Gas Systems, Cryogenic Systems and Components, LNG Applications, Beverage Liquid CO2 Systems, and Cryogenic Services. The Company is a supplier of cryogenic bulk storage systems (stationary tanks, trailers, and ISO tanks) of various sizes ranging from 500 gallons to 250,000 gallons. End use customers for its cryogenic storage equipment include industrial gas producers and distributors, chemical producers, manufacturers of electrical components, health care organizations, food processors and businesses in the oil and natural gas industries.

The Company is supplier of cryogenic packaged gas systems of various sizes ranging from 160 liters to 3,000 liters. Cryogenic liquid cylinders are used extensively in the packaged gas industry to allow smaller quantities of liquid to be easily delivered to the customers of industrial gas distributors on a full-for-empty or fill-on-site basis. Principal customers for its liquid cylinders are th! e same gl! obal industrial gas producers and the North American industrial gas distributors who purchase its cryogenic bulk storage systems. It has developed two technologies in the packaged gas product area: ORCA Micro-Bulk systems and Tri-fecta Laser Gas assist systems. ORCA Micro-Bulk systems bring the ease of use and distribution economics of bulk gas supply to customers formerly supplied by high pressure or cryogenic liquid cylinders. The Tri-fecta Laser Gas assist system was developed to meet the assist gas performance requirements for new high powered lasers being used in the metal fabrication industry. The Company�� line of cryogenic components, including VIP, engineered bulk gas installations, specialty liquid nitrogen (LN2), end-use equipment and cryogenic flow meters are recognized in the market for their reliability, quality and performance. These products are sold to industrial gas producers, as well as to a diverse group of distributors, resellers and end users.

The Company supplies cryogenic solutions for the storage, distribution, vaporization, and application of LNG. LNG may be utilized as a primary source of heat or power at industrial or residential complexes located away from a natural gas pipeline. LNG may also be used for peak shaving or as a backup supply at remote locations. It refers to its LNG distribution products as a Virtual Pipeline as the natural gas pipeline is replaced with cryogenic distribution to deliver the gas to the end user. It supplies cryogenic trailers, bulk storage tanks, tap-off facilities, and vaporization equipment specially configured for LNG into Virtual Pipeline applications. LNG may also be used as a fuel to power vehicles or ships. The Beverage Liquid CO2 Systems product line consists primarily of vacuum insulated, bulk liquid CO2 containers used for beverage carbonation in restaurants, convenience stores and cinemas, in sizes ranging from 100 pounds to 750 pounds of liquid CO2 storage. It also manufactures and market non-insulated, bulk fountain ! syrup con! tainers for side-by-side installation with its CO2 systems. Its beverage systems are sold to national restaurant chains, soft drink companies and CO2 distributors. Its primary competitors for bulk liquid CO2 beverage delivery systems are Taylor-Wharton and other producers of high-pressure gaseous CO2 cylinders. The Company operates locations in the United States and Europe providing installation, service, repair and maintenance of cryogenic products, including storage tanks, liquid cylinders, cryogenic trailers, cryogenic railcars, cryogenic pumps, cryogenic flow meters and VIP.

BioMedical Segment

The Company�� BioMedical segment consists of various product lines built around its core competencies in cryogenics and pressure swing adsorption, but with a focus on the respiratory and biological users of the liquids and gases instead of the large producers and distributors of cryogenic liquids. Its products in the BioMedical segment include Respiratory Products, Cold Storage Systems, and Commercial Oxygen Generation Systems. Its respiratory oxygen product line consists of a range of medical respiratory products, including liquid oxygen systems and ambulatory oxygen systems, both of which are used primarily for the in-home supplemental oxygen treatment of patients with chronic obstructive pulmonary diseases, such as bronchitis, emphysema and asthma.

The Cold Storage Systems product line consists of vacuum insulated containment vessels for the storage of biological materials. The primary applications for this product line include medical laboratories, biotech/pharmaceutical, research facilities, blood and tissue banks, veterinary laboratories, large-scale repositories and artificial insemination, particularly in the beef and dairy industry.

The Company competes with Linde, Sumitomo, Kobe, Fives, Linde, Air Products, Praxair, Air Liquide, Taylor-Wharton International or Taylor-Wharton and CVA/INOX, Taylor-Wharton and Beijing Tenhai Industrial Cylinders, Acme Cr! yogenics,! Vacuum Barrier Corporation, and Ind-Burma Petroleum Company.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Top losers in the sector included Chart Industries (NASDAQ: GTLS), Jacobs Engineering Group (NYSE: JEC), and ABB (NYSE: ABB).

    Top Headline
    Merck & Co (NYSE: MRK) reported a 7% rise in its first-quarter profit. Merck's quarterly profit surged to $1.71 billion, or $0.57 per share, compared to a year-ago profit of $1.59 billion, or $0.52 per share. Excluding certain items, Merck earned $0.88 per share, up from $0.85 per share Its revenue dropped 4% to $10.26 billion versus $10.67 billion. However, analysts were estimating earnings of $0.79 per share on revenue of $10.43 billion. Merck reiterated its full-year earnings forecast of $2.15 to $2.47 per share.

10 Best Healthcare Equipment Stocks To Own Right Now: comScore Inc.(SCOR)

comScore, Inc. provides a range of digital analytics solutions primarily in the United States, Europe, and Canada. The company offers its customers with information regarding usage of their online properties and those of their competitors, coupled with information on consumer demographic characteristics, attitudes, lifestyles, and offline behavior solutions through its digital media measurement platforms. Its digital media measurement platforms consist of proprietary databases and a computational infrastructure that measures, analyzes, and reports on digital activity. The company also provides audience analytics tools that measure the size, behavior, and characteristics of Internet users on PCs, mobile devices, and tablets, as well as insight into online advertising; and advertising analytics products, such as AdEffx, Media Planner 2.0, and Campaign Essentials, which provide solutions for developing, executing, and evaluating online advertising campaigns, as well as valida ted campaign essentials that provide intelligence regarding validated impressions. In addition, it offers Web analytics products and solutions, as well as Web analytics platform that integrates data from multiple sources, including Web, mobile, video, and social media interactions; and mobile and network analytics products, such as comprehensive market intelligence and network solutions to mobile carriers with information on network optimization and capacity planning, customer experience, and market intelligence. The company serves Internet service providers, investment banks, media and digital agencies, consumer banks, wireless carriers, pharmaceutical makers, credit card issuers, and consumer packaged goods companies. comScore, Inc. was founded in 1999 and is headquartered in Reston, Virginia.

Advisors' Opinion:
  • [By Evan Niu, CFA]

    What: Shares of comScore (NASDAQ: SCOR  ) scored major gains today, up by as much as 24% after the company reported first-quarter earnings.

  • [By Paul Ausick]

    Last year, online shoppers spent $1.46 billion on Cyber Monday according to data from comScore Inc. (NASDAQ: SCOR) and the research firm is projecting that total online spending for the 2013 holiday season will rise from $144 billion a year ago to $164 billion this year. That total includes only desktop PC shopping, and does not take into account traffic and sales from mobile devices like tablets and smartphones.

Top 10 Diversified Bank Companies To Invest In Right Now

When it comes to flying, Southwest makes the experience a lot easier to handle than its peers.

That's according to a new index to be released today that ranks companies based on how simple they are to engage with.

Southwest was the highest-ranked travel company, coming in at No. 9 out of 125 businesses whose brands are well-known in the U.S., according to a survey by New York-based strategic branding firm Siegel and Gale. The low-cost carrier leaped six spots from where U.S.-based respondents ranked it last year. Amazon was No. 1.

The perception that Southwest offers fair prices that don't dramatically spike because of a host of extra fees being tacked on is key to customers feeling the airline is easy to deal with, says Brian Rafferty, director of global research for Siegel and Gale. "Transparency is one thing Southwest is doing well,'' he says, "and people also . . .feel they have very good service and they care about the customer.''

Top 10 Rising Stocks To Watch For 2015: Chatham Lodging Trust (REIT)

Chatham Lodging Trust is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It primarily invests in premium-branded upscale extended-stay and select-service hotels to create its portfolio. Chatham Lodging Trust was founded on October 26, 2009 and is based in Palm Beach, Florida.

Advisors' Opinion:
  • [By GURUFOCUS]

    LTC Properties Inc. (LTC) operates as a health care real estate investment trust (REIT) in the United States.Yield: 5.2%

    Gladstone Commercial Corporation (GOOD) operates as a real estate investment trust (REIT) in the United States.Yield: 7.9%

  • [By Dividend Monk]

    OverviewDigital Realty Trust, Inc. (NYSE: DLR) is a large Real Estate Investment Trust (REIT) that focuses on data centers.

    Digital Realty provides a number of services, including turn-key modular data center solutions (accounting for 57% of DLR�� rent income) where Digital Realty does practically all of the work, or powered-base buildings (accounting for 32% of DLR�� rent income) where they focus on the real estate, shell, and electrical/mechanical aspects while the client company focuses on the critical data center aspects. Smaller aspects of the business contribute the remaining revenue.

  • [By Damian Illia]

    Recently, the company decided to reorganize its structure in order to qualify as a Real Estate Investment Trust (REIT) for tax purposes. Therefore, since Jan. 1, 2014, as a REIT, Crown Castle is able to pay at least 90% of its taxable income to shareholders in the form of dividends every year while driving tax savings and cash flows. Company�� financials for fourth quarter 2013 where above analysts��estimations, with an extensive tower portfolio, expansion of Small Cell business, aggressive deployment of 4G LTE and VoLTE networks and increased usage of smartphones. Moreover, the fact that Crown Castle has more than 97% of the coming year's revenue projections already under contract, has added serious stability to the company�� mid-term performance.

Top 10 Diversified Bank Companies To Invest In Right Now: Fomento Economico Mexicano SAB de CV (FMX)

Fomento Economico Mexicano, S.A.B. de C.V. (FEMSA), incorporated on May 30, 1936, is a holding company. The Company conducts its operations through principal holding companies, each of which it refers to as a principal sub-holding company. These companies are Coca-Cola FEMSA, S.A.B. de C.V. (Coca-Cola FEMSA), which engages in the production, distribution and marketing of soft drinks, and FEMSA Comercio, S.A. de C.V. (FEMSA Comercio), which operates convenience stores. The Company�� convenience store chain OXXO operated a total of 7,492 stores as of March 31, 2010. Compania Internacional de Bebidas, S.A. de C.V. (CIBSA) owns a 53.7% interest in Coca-Cola FEMSA. On April 30, 2010, FEMSA announced the closing of the transaction, pursuant to which FEMSA agreed to exchange 100% of its beer operations conducted by FEMSA Cerveza for a 20% economic interest in the Heineken Group. In February 2009, Coca-Cola FEMSA acquired with The Coca-Cola Company the Brisa bottled water business in Colombia from Bavaria, a subsidiary of SABMiller. Coca-Cola FEMSA acquired the production assets and the rights to distribute in the territory, and The Coca-Cola Company obtained the Brisa brand.

Coca-Cola FEMSA, S.A.B. de C.V.

Coca-Cola FEMSA is a bottler of Coca-Cola trademark beverages. Coca-Cola FEMSA operates in various territories, including Mexico, a substantial portion of central Mexico (including Mexico City and the states of Michoacan and Guanajuato) and southeast Mexico (including the Gulf region); Central America, including Guatemala (Guatemala City and surrounding areas), Nicaragua (nationwide), Costa Rica (nationwide) and Panama (nationwide); Colombia; Venezuela; Argentina, including Buenos Aires and surrounding areas, and Brazil, including the area of greater Sao Paulo, Campinas, Santos, the state of Mato Grosso do Sul, the state of Minas Gerais and part of the state of Goias.

Coca-Cola FEMSA produces, markets and distributes Coca-Cola trademark beverages, own brands and b! rands licensed from the Company. The Coca-Cola trademark beverages include sparkling beverages (colas and flavored sparkling beverages), water, and still beverages (including juice drinks, ready-to-drink teas and isotonics). Out of the more than 100 brands and line extensions of beverages sold and distributed by Coca-Cola FEMSA, its most important brand, Coca-Cola, together with its line extensions, Coca-Cola light, Coca-Cola Zero and Coca-Cola light caffeine free, accounted for 61.4% of total sales volume during the year ended December 31, 2009. Coca-Cola FEMSA�� next largest brands, Ciel (a water brand from Mexico), Fanta (and its line extensions), Sprite (and its line extensions), ValleFrut and Hit, accounted for 10.5%, 5.8%, 2.6%, 1.5% and 1.3%, respectively, of total sales volume in 2009. Coca-Cola FEMSA uses the term line extensions to refer to the different flavors in which it offers its brands.

Coca-Cola FEMSA produces, markets and distributes Coca-Cola trademark beverages in each of its territories in containers authorized by The Coca-Cola Company, which consist of a variety of returnable and non-returnable presentations in the form of glass bottles, cans and plastic bottles made of polyethylene terephtalate (PET). Coca-Cola FEMSA uses the term presentation to refer to the packaging unit in which it sells its products. Presentation sizes for its Coca-Cola trademark beverages range from a 6.5-ounce personal size to a 3-liter multiple serving size. For all of its products excluding water, Coca-Cola FEMSA considers a multiple serving size as equal toor larger than one liter. In addition, it sells some Coca-Cola trademark beverage syrups in containers designed for soda fountain use, which it refers to as fountain. It also sells bottled water products in bulk sizes, which refers to presentations equal to or larger than five liters, which have a much lower average price per unit case than its other beverage products.

In Mexico, Coca-Cola FEMSA�� product portfolio consis! ts of Coc! a-Cola trademark beverages, and includes Mundet trademark beverages licensed from FEMSA in some Mexican territories. Coca-Cola FEMSA�� product sales in Latincentro consist predominantly of Coca-Cola trademark beverages. Per capita consumption of its sparkling beverages products in Colombia and Central America was 92 and 146 eight-ounce servings, respectively, in 2009. Its product portfolio in Venezuela consists of Coca-Cola trademark beverages. Sparkling beverages per capita consumption of its products in Venezuela was 174 eight-ounce servings during 2009. Coca-Cola FEMSA�� product portfolio in Mercosur consists mainly of Coca-Cola trademark beverages, and the Kaiser beer brand in Brazil, which Coca-Cola FEMSA sells and distributes on behalf of FEMSA Cerveza. Sparkling beverages per capita consumption of its products in Brazil and Argentina was 214 and 359 eight-ounce servings, respectively, in 2009.

The Company competes with Pepsi Beverage Company, Grupo Embotelladores Unidos, S.A.B. de C.V., Grupo Jumex, Groupe Danone, Cadbury Schweppes, Big Cola, Consorcio AGA, S.A. de C.V., Postobon, Florida Ice and Farm Co. S.A., Cerveceria Nacional, S.A., Pepsi-Cola Venezuela, C.A., AmBev and Quilmes Industrial S.A.

FEMSA Comercio, S.A. de C.V.

FEMSA Comercio operates a chain of convenience stores in Mexico, under the trade name OXXO. OXXO stores are concentrated in the northern part of Mexico, but also have a presence in central Mexico and the Gulf coast. FEMSA Comercio is the largest single customer of FEMSA Cerveza and of the Coca-Cola system in Mexico. During 2009, a typical OXXO store carried 1,954 different store keeping units (SKUs) in 31 main product categories.

The Company competes with 7-Eleven, Super Extra, Super City, Circle-K and AM/PM.

Advisors' Opinion:
  • [By Dividends4Life]

    Memberships and Peers: PEP is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: The Coca-Cola Company (KO) with a 2.8% yield, Dr Pepper Snapple Group, Inc. (DPS) with a 3.2% yield and Fomento Econ (FMX) with a 1.7% yield.

  • [By Dividends4Life]

    Memberships and Peers: KO is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: Dr. Pepper Snapple Group (DPS) with a 3.2% yield, Pepsico Inc (PEP) with a 2.6% yield and Fomento Economico ADR (FMX) with a 1.7% yield.

Top 10 Diversified Bank Companies To Invest In Right Now: Amgen Inc.(AMGN)

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Advisors' Opinion:
  • [By Marc Bastow]

    Now, before we get to the list, I’ll admit the thought of taking a bit of a flyer with “found” money crossed my mind. Dan Burrows suggested that doubling up on some current winners could pay out well, and any of the the three he suggests could be worth the gamble. However, I might look at biotechnology giant Amgen (AMGN). The company is at the forefront of genetically based research for cancer, anemia and other illnesses; it pays a dividend (unlike most biotechs); and it trades for just under a 20x P/E multiple.

  • [By Sean Williams]

    Onyx Pharmaceuticals (NASDAQ: ONXX  ) is having a garage sale, but it doesn't appear that Amgen (NASDAQ: AMGN  ) has been invited.

  • [By Peter Stephens]

    Fourth-quarter results released by Amgen (NASDAQ: AMGN  ) were roughly in line with Wall Street estimates. So, while shares didn't react particularly strongly (and have pretty much tracked the wider Nasdaq index since their release), there were a number of positives in the results that investors should be happy to hear about.

Top 10 Diversified Bank Companies To Invest In Right Now: Chemung Financial Corp (CHMG)

Chemung Financial Corporation, incorporated on January 2, 1985, is a financial holding company. The Company was organized for the purpose of acquiring Chemung Canal Trust Company (the Bank). The Company provides a range of financial services, such as insurance products, mutual funds, and brokerage services. The subsidiaries of the Company include Chemung Canal trust Company and CFS Group, Inc. CFS Group, Inc. offers a range of financial services including mutual funds, full and discount brokerage services, annuity and other insurance products and tax preparation services. Chemung Canal Trust Company is a full-service community bank with full trust powers. The Company manages its operations through two primary business segments: core banking and wealth management group services. The core banking segment provides revenues by attracting deposits from the general public and using such funds to originate consumer, commercial, commercial real estate, and residential mortgage loans, primarily in the Company�� local markets and to invest in securities. The wealth management group services segment provides revenues by providing trust and investment advisory services to clients.

The Bank is a New York chartered commercial bank, which engages in full-service commercial and consumer banking and trust business. The Bank's services include accepting time, demand and savings deposits, including negotiable order of withdrawal (NOW) accounts, savings accounts, insured money market accounts, investment certificates, fixed-rate certificates of deposit and club accounts. The Bank's services also include making secured and unsecured commercial and consumer loans, financing commercial transactions (either directly or participating with regional industrial development and community lending corporations), and making commercial, residential and home equity mortgage loans, revolving credit loans with overdraft checking protection and small business loans. Additional services include renting safe deposit faciliti! es and the provision of networked automated teller facilities and an Internet banking product featuring bill payment services. Wealth management services provided by the Bank include services as executor and trustee under wills and agreements, and guardian, custodian, trustee and agent for pension, profit-sharing and other employee benefit trusts, as well as various investment, pension, estate planning and employee benefit administrative services.

Lending Activities

At December 31, 2011, 22.5% of the Corporation�� loans consist of commercial real estate loans to borrowers in the real estate, rental or leasing sector. The major portion of this sector comprises borrowers that rent, lease or otherwise allow the use of their own assets by others. The Bank�� loan portfolio includes commercial, financial and agricultural loans, commercial mortgages, residential mortgages, indirect consumer loans, and consumer loans. As of December 31, 2011, the total loan portfolio of the Bank was at $796,915,000.

Investment Activities

The Bank�� investment portfolio consists of obligations of the United States Government and the United States Government sponsored entities; mortgage-backed securities, residential; obligations of states and political subdivisions; corporate bonds and notes; SBA (small business administration ) loan pools; trust preferred securities, and corporate stocks. As of December 31, 2011, the investment portfolio of the Bank was at $289,182,000.

Sources of Funds

The Bank�� source of funds includes non-interest-bearing demand deposits, interest-bearing demand deposits, savings and insured money market deposits, and time deposits. As at December 31, 2011, the total deposits of the Bank was at $965,183,000.

Advisors' Opinion:
  • [By Doug Hughes]

    Steve Halpern: Okay, today we��e going to walk through two specific investment ideas that you find attractive in the banking sector. The first is Chemung Financial (CHMG), a New York-based operation that happens to be one of the oldest banks in the country. Could you tell us a little more about that?

Top 10 Diversified Bank Companies To Invest In Right Now: NYSE Euronext Inc.(NYX)

NYSE Euronext, through its subsidiaries, operates securities exchanges. It operates various stock exchanges, including the New York Stock Exchange (NYSE), NYSE Arca, Inc., and NYSE Amex LLC in the United States; and five European-based exchanges that comprise Euronext N.V. ? the Paris, Amsterdam, Brussels, and Lisbon stock exchanges, as well as the NYSE Liffe derivatives markets in London, Paris, Amsterdam, Brussels, and Lisbon. The company?s Derivatives segment provides access to trade execution in derivatives products, options, and futures; offers clearing services for derivative products; and sells and distributes market data and related information. NYSE Euronext?s Cash Trading and Listings segment engages in offering access to trade execution in cash trading and settlement of transactions in European markets; obtaining new listings and servicing existing listings; selling and distributing market data and related information; and providing regulatory services. Its Info rmation Services and Technology Solutions segment operates sell side and buy side connectivity networks for its markets and for other market centers, and market participants in the United States, Europe, and Asia; provides trading and information technology software and solutions; sells and distributes market data and related information to data subscribers for proprietary data products; and offers asset management services, and consultancy services to exchanges and liquidity centers. The company is headquartered in New York, New York.

Advisors' Opinion:
  • [By Michael P. Regan]

    A computer from NYSE Arca, NYSE Euronext (NYX)�� all-electronic exchange, handling Nasdaq-listed stocks was the machine that had trouble connecting with the SIP, a person familiar with the situation, who asked not to be identified because they were not authorized to discuss the issue, said last week.

Top 10 Diversified Bank Companies To Invest In Right Now: First Trust Health Care AlphaDEX Fund (FXH)

First Trust Health Care AlphaDEX Fund (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield of an equity index called the StrataQuant Health Care Index (the Index). The Index is an enhanced index created and administered by the AMEX, which employs the AlphaDEX stock selection methodology to select stocks from the Russell 1000 Index. The AMEX constructs the Index by ranking the stocks, which are members of the Russell 1000 Index on growth factors, including 3, 6 and 12-month price appreciation, sales to price and one-year sales growth, and separately on value factors, including book value to price, cash flow to price and return on assets. The selected stocks are divided into quintiles based on their rankings and the top ranked quintiles receive a higher weight within the Index. The Index is reconstituted and rebalanced quarterly. The Fund�� investment advisor is First Trust Advisors L.P. Advisors' Opinion:
  • [By David Fabian]

    Another interesting ETF that treads the line between passive and active investing in the healthcare field is the First Trust Health Care AlphaDEX Fund (FXH). This ETF is a smart beta strategy that screens healthcare stocks for book value, cash flow, and return on assets.

Top 10 Diversified Bank Companies To Invest In Right Now: Alon USA Partners LP (ALDW)

Alon USA Partners, LP (Alon USA), incorporated on August 17, 2012, owns and operates refining and petroleum products marketing business. Its integrated downstream business operates primarily in the South Central and Southwestern regions of the United States. It owns and operates a crude oil refinery in Big Spring, Texas with total throughput capacity of approximately 70,000 barrels per day (bpd). The crude oil pipelines the Company utilizes consist of the Amdel, White Oil, Mesa Interconnect, Centurion and Centurion Interconnect. Its Big Spring refinery produces ultra-low sulfur gasoline, ultra-low sulfur diesel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt and other petroleum products.

During the year ended December 31, 2011 and the six months ended June 30, 2012, sour crude, such as West Texas Sour (WTS), represented approximately 80.4% and 80.4% of its throughput, respectively, and sweet crude, such as West Texas Intermediate (WTI), represented approximately 15.8% and 17.1% of its throughput, respectively. For the year ended December 31, 2011 and the six months ended June 30, 2012, the Company produced approximately 49.1% and 49.2% gasoline, 32.3% and 32.5% diesel/jet fuel, 7.1% and 6.4% asphalt, 6.0% and 6.0% petrochemicals and 5.5% and 5.9% other refined products, in each case, respectively. The Company distributes fuel products through a product pipeline and terminal network of seven pipelines totaling approximately 840 miles and six terminals that it owns or access.

The Company competes with Chevron, ExxonMobil and Shell.

Advisors' Opinion:
  • [By Rick Munarriz]

    Wednesday
    Alon Partners USA (NYSE: ALDW  ) reports on Wednesday. Analysts see the oil refiner earning $1.36 per unit on Wednesday, and that's welcome news for investors. Alon Partners is set up as a limited partnership, passing on most of the money it makes to its stakeholders.

Sunday, June 29, 2014

5 Best Asian Stocks To Watch Right Now

5 Best Asian Stocks To Watch Right Now: OM Group Inc.(OMG)

OM Group, Inc. develops, produces, and markets specialty chemicals, advanced materials, and electrochemical energy storage products worldwide. The company operates in three segments: Advanced Materials, Specialty Chemicals, and Battery Technologies. The Advanced Materials segment manufactures inorganic products using unrefined cobalt and other metals and serves the battery materials, powder metallurgy, ceramics, and chemical end markets. It offers cobalt powders, precursors, chemicals, pigments and ceramics, and various raw materials. These products enhance the electrical conduction of rechargeable batteries, as well as strengthen and add durability to diamond and machine cutting tools and drilling equipment. The Specialty Chemicals segment offers electronic chemicals for the printed circuit board, memory disk, general metal finishing, electronic packaging and finishing, and photovoltaic markets. This segment also provides advanced organics comprising additives and driers for paints, and printing inks; rubber adhesion promoters for tires; composite and other catalysts for chemicals; and fuel oil additives, lubricants, and grease additives. In addition, it offers ultra pure chemicals used in the manufacture of electronic and computer components, such as semiconductors, wafers, and liquid crystal displays; and photo-imaging masks, including high-purity quartz or glass plates containing precision, microscopic images of integrated circuits; and reticles for the semiconductor, optoelectronics, and microelectronics industries under the Compugraphics brand name. The Battery Technologies segment provides battery products, primary and secondary batteries, battery management systems, battery chargers, and energetic devices for defense applications; primary and secondary batteries for satellites, aircraft, and the packaging of cells; and miniature batteries ! to power implantable medical devices. The company was founded in 1991 and is headquartered in Cle veland, Ohio.

Advisors' Opinion:
  • [By Laura Brodbeck]

    Friday

    Earnings Expected From: Chevron Corporation (NYSE: CVX), OM Group, Inc. (NYSE: OMG), Public Storage (NYSE: PSA) Economic Releases Expected:  US ISM manufacturing index, Canadian manufacturing PMI, British manufacturing PMI, Norwegian unemployment rate

    Posted-In: Bank Of England Federal ReserveNews Eurozone Commodities Previews Global Economics Federal Reserve After-Hours Center Markets Trading Ideas Best of Benzinga

  • [By Rich Smith]

    KMG Chemicals (NYSE: KMG  ) is buying OM Group's (NYSE: OMG  ) Ultra Pure Chemicals subsidiaries in the U.S., U.K., Singapore, and perhaps in France as well.

  • [By Brian Pacampara]

    What: Shares of specialty chemical company OM Group (NYSE: OMG  ) climbed 14% today after its quarterly results easily topped Wall Street expectations.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/5-best-asian-stocks-to-watch-right-now.html

Saturday, June 28, 2014

Top 10 Biotech Stocks To Invest In 2014

Popular Posts: 9 Biotechnology Stocks to Buy Now3 Communications Equipment Stocks to Buy Now4 Pharmaceutical Stocks to Buy Now Recent Posts: 17 “Triple A” Stocks to Buy 17 “Triple A” Stocks to Buy 17 “Triple A” Stocks to Buy View All Posts

This week, 17 stocks get A’s (“strong buy”) in Portfolio Grader‘s three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.

These are the best of the best in the entire Portfolio Grader database. This week, there are 4,279 stocks and only these 17 get top marks in all categories to make the elite “Triple A” stocks list. Here they are:

Top 10 Gas Stocks To Own Right Now: Intellicell Biosciences Inc (SVFC)

Intellicell Biosciences, Inc., formerly Media Exchange Group, Inc., incorporated on March 8, 1999, is engaged in regenerative medicine company focused on the expanding regenerative medical markets using a process to separate adult autologous vascular cells (AAVC's) from blood vessels in adult adipose (fat) tissue. The Company is also exploring and undertaking, either on its own or in collaboration with a third party, providing a service for the collection, processing and storage of autologous cells for future use. As of December 31, 2011, the Company has developed technologies that allow reproducible separation of stromal vascular fraction (IntelliCell) containing adipose stem cells that can be performed in tissue processing centers and in doctors��offices. On June 3, 2011, the Company completed the acquisition of Intellicell Biosciences, Inc. The Company formed a wholly-owned subsidiary, ICBS Research, Inc.

The Company's process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue, which results in the separation AAVC's from the blood vessels in adult adipose (fat) tissue. This AAVC, or stromal vascular fraction (IntelliCells), are removed from the patient at the point of care, and separated at the point of care under the supervision of its certified technicians following current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs), and the cells are then returned to the medical professionals at the point of care for use a patient's own body (autologous treatment), by way of a same-day clinical procedure for homologous use of these cells.

Intellicell Biosciences, Inc., formerly Media Exchange Group, Inc., incorporated on March 8, 1999, is engaged in regenerative medicine company focused on the expanding regenerative medical markets using a process to separate adult autologous vascular cells (AAVC's) from blood vessels in adult adipose (fat) tissue. The Company is also exploring and undertaking, either on ! its own or in collaboration with a third party, providing a service for the collection, processing and storage of autologous cells for future use. As of December 31, 2011, the Company has developed technologies that allow reproducible separation of stromal vascular fraction (IntelliCell) containing adipose stem cells that can be performed in tissue processing centers and in doctors��offices. On June 3, 2011, the Company completed the acquisition of Intellicell Biosciences, Inc. The Company formed a wholly-owned subsidiary, ICBS Research, Inc.

The Company's process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue, which results in the separation AAVC's from the blood vessels in adult adipose (fat) tissue. This AAVC, or stromal vascular fraction (IntelliCells), are removed from the patient at the point of care, and separated at the point of care under the supervision of its certified technicians following current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs), and the cells are then returned to the medical professionals at the point of care for use a patient's own body (autologous treatment), by way of a same-day clinical procedure for homologous use of these cells.

The Company competes with Cytori Therapeutics, Stem Cell Assurance, Inc., Osiris, Aastrom Biosciences, Aldagen, BioTime, Baxter International, Celgene, Geron, Harvest Technologies, Mesoblast, Regenexx, NeoStem, X-Cell Center, Stem Cells, Athersys, and Tissue Genesis, Life Technologies, Asterand, pacific biosciences of california inc. and AllCells, LLC.

Advisors' Opinion:
  • [By Bryan Murphy]

    Well, though I give myself a C for timing, it looks like I'm going to be able to give myself an A for stock-picking. Back on January 27th I deemed IntelliCell BioSciences, Inc. (OTCMKTS:SVFC) was a compelling buy, and though SVFC was stagnant for a month after that, it looks like the stock's finally getting on its horse. If you didn't get it then, you may want to get in now.

  • [By Bryan Murphy]

    To say that shares of IntelliCell BioSciences, Inc. (OTCMKTS:SVFC) has been disappointing since 2011 would be an understatement. SVFC has been an outright disaster since 2011, falling from a peak of $19.00 to a low of, well, just a few pennies as of late last year. In fact, there are those who are understandably wondering how the company is still alive, only producing about a half a million dollars in revenue in 2012, and then dialing that figure back down to nothing for the last few quarters. Yet, there's just something about a company that refuses to go away.... something compelling now.

Top 10 Biotech Stocks To Invest In 2014: Hemispherx Biopharma Inc (HEB)

Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.The commercial focus for Ampligen includes application as a treatment for Chronic Fatigue Syndrome (CFS) and as an influenza vaccine enhancer (adjuvant) for both therapeutic and preventative vaccine development. Alferon N Injection is a United States Food and Drug Administration (FDA) approved product with an indication for refractory or recurring genital warts. Alferon LDO (Low Dose Oral) is a formulation under development targeting influenza. It has three subsidiaries BioPro Corp., BioAegean Corp., and Core BioTech Corp. The Company's foreign subsidiary is Hemispherx Biopharma Europe N.V./S.A.

Ampligen

Ampligen is an experimental drug, which is undergoing clinical development for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Over 1,000 patients have participated in the Ampligen clinical trials representing the administration of more than 90,000 doses of this drug. The Company is also engaged in ongoing, experimental studies assessing the efficacy of Ampligen against influenza viruses.

Alferon N Injection

Alferon N Injection is the registered trademark for the Company's injectable formulation of natural alpha interferon. Interferons are a group of proteins produced and secreted by cells to combat diseases. The Company's natural alpha interferon is produced from human white blood cells. Alferon N Injection [Interferon alfa-n3 (human leukocyte derived)] is a highly purified, natural-source, glycosylated, multi-species alpha interferon product.

Alferon LDO (Low Dose Oral)

Alferon LDO [Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)]! is an experimental low-dose, oral liquid formulation of Natural Alpha Interferon and like Alferon N Injection should not cause antibody formation, which is a problem with recombinant interferon. It is an experimental immunotherapeutic that works by stimulating an immune cascade response in the cells of the mouth and throat, enabling it to bolster systemic immune response through the entire body by absorption through the oral mucosa.

The Company competes with Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Baxter International, Fletcher/CSI, AVANT Immunotherapeutics, AVI BioPharma and Genta.

Advisors' Opinion:
  • [By MONEYMORNING]

    Hemispherix Biopharma Inc. (NYSE: HEB) is a specialty pharmaceutical company. It engages in the clinical development of new drug therapies based on natural immune system enhancing technologies and targets the treatment of viral and immune-based clinical disorders. The Philadelphia, Pa.-headquartered company gained widespread attention over the last several months for its work on flu research. Its flagship products include Alferon N Injection, approved by the FDA for a category of sexually transmitted disease infection. Experimental treatments include Ampligen and Oragens, in development stages for the potential treatment of global viral diseases and disorders of the immune system including human papilloma virus, human immunodeficiency virus, chronic fatigue syndrome, hepatitis, and influenza. Shares have traded as low as $0.18 and as high as $0.55 over the last year. At last check, shares were changing hands around $0.50 on volume of 2 million shares.

Top 10 Biotech Stocks To Invest In 2014: Clovis Oncology Inc (CLVS)

Clovis Oncology, Inc. (Clovis) incorporated on April 20, 2009, is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also focuses on the treatment of specific subsets of cancer populations. During the year ended December 31, 2010, the Company was in the process of developing three product candidates for which it holds global marketing rights: CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine; CO-1686, an oral epidermal growth factor receptor (EGFR) mutant-selective inhibitor and CO-338, a poly ADP (Adenosine Diphosphate)-ribose polymerase (PARP) inhibitor. Effective November 19, 2013, Clovis Oncology Inc acquired the entire share capital of Ethical Oncology Science SpA.

CO-101 - a Lipid-Conjugated Form of the Anti-Cancer Drug Gemcitabine

CO-101 is designed to treat patients with pancreatic cancer whose tumors express low amounts of a membrane transporter protein on the surface of the cancer cell known as hENT1 and are thus expected to be resistant to standard gemcitabine-based therapy. Based on the published results of multiple studies assessing the correlation of hENT1 expression to survival outcomes in pancreatic cancer patients treated with gemcitabine, the Company estimates that approximately 40% to 50% of pancreatic patients express low levels of hENT1, and thus derive little or no benefit from gemcitabine therapy. CO-101 is in an international, randomized and controlled 360-patient study for the first-line treatment of metastatic pancreatic cancer. This open-label study compares CO-101 to gemcitabine as a first-line therapy in patients with metastatic pancreatic cancer. Clovis is partnered with Ventana Medical Systems for the development and commercialization of a companion diagnostic for the assessment of hENT1 levels.

CO-1686-an Oral EGFR Mutant-Selective ! Inhibitor

CO-1686 is an orally available, small molecule covalent inhibitor of the cancer-causing mutant forms of EGFR for the treatment of non-small cell lung cancer (NSCLC). CO-1686 targets both the initial activating EGFR mutations as well as the primary resistance mutation, T790M, it treats both first- and second-line NSCLC patients with EGFR mutations. Such initiating activating mutations occur in approximately 10% to 15% of NSCLC cases in Caucasian patients and approximately 30% to 35% of NSCLC cases in East Asian patients. Following treatment with approved NSCLC therapies, Tarceva (erlotinib) or Iressa (gefitinib), both known as tyrosine kinase inhibitors (TKIs), approximately half of these patients develop the T790M mutation.

The Company focuses on the development of CO-1686 as both a second-line therapy for EGFR-mutated NSCLC patients who become resistant to TKIs due to the emergence of the T790M secondary mutation and as a first-line treatment for EGFR-mutated NSCLC. Clovis is partnered with Roche Molecular Systems for the development and commercialization of a companion diagnostic for identification of EGFR mutations.

CO-338-a PARP Inhibitor

CO-338 is a small molecule PARP inhibitor that the Company focuses to develop as both monotherapy and in combination with chemotherapeutic agents for the treatment of selected cancer patients. CO-338 is in a Phase I clinical trial to determine the maximum tolerated dose of oral CO-338 that can be combined with intravenous, or IV, platinum chemotherapy in the treatment of solid tumors. This program is supplemented by two ongoing investigator-initiated trials, using the IV formulation of CO-338: a Phase I/II study in germ-line BRCA mutant breast and ovarian cancer and a Phase II study in the adjuvant treatment of germ-line BRCA mutant and triple-negative breast cancer. The Company also focuses on initiating a Phase I monotherapy study of the oral formulation, to determine an appropriate dose and schedule.!

The Company competes with Eli Lilly, Teva Pharmaceutical Industries, APP Pharmaceuticals, AB Science SA, Amgen Inc., Astellas Pharma, BioSante Pharmaceuticals, Inc., Celgene Corporation, Immunomedics, Inc., Lorus Therapeutics, Threshold Pharmaceuticals, Inc., Boehringer Ingelheim, Pfizer, Sanofi-Aventis, Astra Zeneca, Abbott, Merck, Eisai, Cephalon and Biomarin.

Advisors' Opinion:
  • [By Lauren Pollock]

    Biotech company Clovis Oncology Inc.(CLVS), which was considering a sale, didn’t enter any deal talks and is no longer seeking bids, Bloomberg News reported, citing a person with knowledge of the matter. Shares dropped 14% to $63.51 premarket.

Top 10 Biotech Stocks To Invest In 2014: Chromadex Corp (CDXC)

Chromadex Corporation, incorporated on June 19, 2008, is a provider of research and quality-control products and services to the natural products industry. The Company�� products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries. The Company together with its subsidiaries supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of potential attributes, and reference materials, related contract services, technical consulting and ingredients. On December 3, 2012, ChromaDex Inc. acquired Spherix Consulting Inc. The Company�� principal subsidiaries include ChromaDex, Inc., Chromadex Analytics, Inc. and Spherix Consulting, Inc (Spherix).

The Company provides its clients in the food, supplement and pharmaceutical industries with solutions to manage potential health and regulatory risks. Its science-based solutions are for both new and existing products that may be subject to product liability and/or exposed to changing scientific standards or public perceptions; literature evaluations, and design and assessment of pre-clinical and clinical safety testing. It specializes in regulatory submissions for food and dietary supplement ingredients. For its clients involved in drug development within the pharmaceutical industry, the Company provides similar services, as well as risk-based strategies, including intellectual property data and compliance gap identification, due diligence assessments and investigational new drug writing.

Products and Services

The Company offers bulk raw materials for inclusion in dietary supplements, food, beverage and cosmetic products. Through its catalog, it supplies a range of products necessary to conduct quality control of raw materials and consumer products. The Company through Chromadex Analytics, provides a range of contract services ranging from routine contract analysis for the production of dietary sup! plements, cosmetics, foods and other natural products to elaborate contract research for clients in these industries. The Company provides a range of consulting services in the areas of regulatory support, new ingredient or product development, risk management and litigation support. With an addition of Spherix, it provides regulatory approval and scientific advisory services.

The Company competes with Sigma-Aldrich, Phytolab, US Pharmacopoeia, Extrasynthese, Covance, Eurofins, and Silliker Canada Co.

Advisors' Opinion:
  • [By Peter Graham]

    Small cap stocks Chromadex Corp (OTCMKTS: CDXC) and 22nd Century Group Inc (OTCBB: XXII) are, one way or the other, focused on natural products and have been getting some extra attention lately. Moreover, one of these stocks have been the subject of a disclosed investor awareness campaign. Keeping that in mind, are these two small cap stocks natural winners for investors? Here is a quick look:

Top 10 Biotech Stocks To Invest In 2014: Sucampo Pharmaceuticals Inc (SCMP)

Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�� prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�� products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl).

AMITIZA

The Company�� AMITIZA is being marketed in the United States for three gastrointestinal indications under a license agreement, or the Takeda Agreement, with Takeda Pharmaceutical Company Limited, or Takeda. The three gastrointestinal indications include chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. AMITIZA for OIC received approval from the United States Food and Drug Administration (FDA), in April 2013. In Japan, AMITIZA is marketed under a license, commercialization and supply agreement, or the Abbott Agreement, with Abbott Japan Co. Ltd. (Abbott), for the gastrointestinal indication of chronic constipation (CC), excluding constipation caused by organic diseases. In Switzerland, the Company is marketing AMITIZA.

RESCULA

The Company holds license agreements for RESCULA in the United States and Canada and the rest of the world, with the exception of Japan, Korea, Taiwan and the People�� Republic of China. The Company is commercializing RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% for the lowering of intraocular pressure (IOP), in patients with open-angle glaucoma or ocular hypertension in the United States. RESCULA may be used as an agent or concomit! antly with other topical ophthalmic drug products to lower intraocular pressure. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.

Advisors' Opinion:
  • [By James Brumley]

    Still, for the nimble who know when to get out, OREX is one of the few cheap stocks worth a closer look.

    Sucampo Pharmaceuticals (SCMP)

    Finally, though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve seen SCMP stock suffer since peaking in mid-January. It’s not a pullback that’s bound to go unchallenged by the bulls.

  • [By Roberto Pedone]

    Another under-$10 stock that's starting to trend within range of triggering a major breakout trade is Sucampo Pharmaceuticals (SCMP), which is engaged in the discovery, development and commercialization of proprietary drugs based on prostones, and other novel drug technologies. This stock is off to a decent start in 2013, with shares up by 26%.

    If you take a look at the chart for Sucampo Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last four months, with shares dumping hard from its high of $10.48 to its recent low of $5.40 a share. During that downtrend, shares of SCMP have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the downside volatility for SCMP looks to be over in the short-term since the stock has started to reverse its downtrend and enter an uptrend. That reverse is quickly pushing shares of SCMP within range of triggering a major breakout trade above a key downtrend line.

    Traders should now look for long-biased trades in SCMP if it manages to break out above some near-term overhead resistance levels at $6.33 to $6.66 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 115,383 shares. If that breakout triggers soon, then SCMP will set up to re-test or possibly take out its next major overhead resistance levels at $7.09 to $7.67 a share. Any high-volume move above those levels will then give SCMP a chance to tag $8 to $9 a share.

    Traders can look to buy SCMP off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $5.58 to $5.40 a share. One can also buy SCMP off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Biotech Stocks To Invest In 2014: Gilead Sciences Inc.(GILD)

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.

Advisors' Opinion:
  • [By Sue Chang]

    Gilead Sciences Inc. (GILD) �is expected to post first-quarter earnings of 89 cents a share.

Top 10 Biotech Stocks To Invest In 2014: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:
  • [By Ben Levisohn]

    Markey rates the stock a Buy with an $11 price target. Shares of MannKind have jumped 14% to $7.85 today. The SPDR Biotech ETF (XBI) has gained 0.7% to $119.85 today, while Alnylam Pharmaceuticals (ALNY) has gained 1% to $49.05, NPS Pharmaceuticals (NPSP) has fallen 4.1% to $23.56, and InterMune (ITMN) has risen 2.6% to $14.89.

  • [By Jake L'Ecuyer]

    Equities Trading UP
    Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up early in the day, but settling on a gain of 40.40 percent to $92.96 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Top 10 Oil Companies To Invest In Right Now

The low-pitched thrum of natural-gas-fired engines vibrates across the rural valley in Pennsylvania�� Susquehanna County, where Cabot Oil & Gas Cabot Oil & Gas is drilling a new well to tap the Marcellus shale formation a mile underground.

As workers swing drilling pipe into the 135-foot-tall rig, a parade of trucks rumbles up the narrow dirt road from Montrose, Pa. Until the shale boom Montrose was best known for its bluestone quarries. Now the roads in this northeastern Pennsylvania county are filled with heavy trucks hauling drilling fluids, pipe and the thousands of tons of sand that drillers pump into the ground to open up fissures in the granite-hard Marcellus and let the gas flow.

Cabot�� Pennsylvania wells are natural gas gushers, expected to produce an average of 14 billion cubic feet over a well�� 50-year life span, 14 times as much as a typical Oklahoma well. Already the Marcellus shale, extending from New York to West Virginia, is supplying 12 billion cubic feet a day, or almost 15% of U.S. gas demand.

Top 10 Regional Bank Companies To Buy For 2015: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Fede Zaldua]

    Halliburton now trades at 11.7 times 2014 earnings and 5.9 times EV/EBITDA. One of its closer competitors in the oil and gas services industry, Schlumberger (SLB) sells for 15.1 times 2014 earnings and 8.6 EV/EBITDA. Its true that Halliburton's third quarter did not impress investors at all. As a matter of fact, the stock reacted negatively when results were released despite the small EPS beat the company achieved ��$0.83 versus $0.82 analysts were expecting. The stock's reaction was related to lower than expected growth (above all in Latin America) and smaller than expected margins in North America. That said, I believe those issues ��slower growth and declining margins ��were given by temporary issues such as the flooding in Colorado which is not an operational issue but a weather-related issue. Once again, I agree with Soros. Halliburton should continue outperfoming and beating its self-imposed targets.

    Currently 0.00/512345

    Rating: 0.0/5 (0 votes)

Top 10 Oil Companies To Invest In Right Now: San Juan Basin Royalty Trust (SJT)

San Juan Basin Royalty Trust (the Trust) is an express trust created by the San Juan Basin Royalty Trust Indenture, between Southland Royalty Company (Southland Royalty) and The Fort Worth National Bank. The Trustee of the Trust is Compass Bank. The function of the Trustee is to collect the net proceeds attributable to the Royalty (Royalty Income), to pay all expenses and charges of the Trust and distribute the remaining available income to the Unit Holders. The Royalty conveyed to the Trust was carved out of Burlington Resources Oil & Gas Company LP�� (Burlington) working interests and royalty interests in certain properties situated in the San Juan Basin in northwestern New Mexico.

Burlington is the principal operator of the Underlying Properties. A percentage of the Royalty Income is attributable to the production and sale by Burlington of natural gas from the Underlying Properties. The Underlying Properties are primarily gas producing properties. The Underlying Properties consist of working interests, royalty interests, overriding royalty interests and other contractual rights in 151,900 gross (119,000 net) producing acres in San Juan, Rio Arriba and Sandoval Counties of northwestern New Mexico and 4,015 gross (1,158.5 net) wells. Gas produced in the San Juan Basin is sold in both interstate and intrastate commerce. Gas production from the properties totaled 32,580,756 million cubic feet (Mcf), during the year ended December 31, 2012. Gas produced from the Underlying Properties is processed at one of the five plants: Chaco, Val Verde, Milagro, Ignacio, and Kutz, all located in the San Juan Basin. Gas produced from the Underlying Properties and processed at Kutz is being sold under three separate contracts with Pacific Gas and Electric Company (PG&E), Shell Energy North America (US), LP (Shell) and New Mexico Gas Company, Inc. (NMGC).

Advisors' Opinion:
  • [By Rich Duprey]

    San Juan Basin Royalty Trust (NYSE: SJT  ) announced yesterday its July monthly distribution of $0.080643�per unit, based principally upon production during the month of April.

Top 10 Oil Companies To Invest In Right Now: VAALCO Energy Inc (EGY)

VAALCO Energy, Inc. (VAALCO), incorporated in 1985, is an independent energy company principally engaged in the acquisition, exploration, development and production of crude oil and natural gas. VAALCO owns producing properties and conducts exploration activities as operator in Gabon, West Africa, conducts exploration activities as an operator in Angola, West Africa, and has conducted exploration activities as a non-operator in the British North Sea. The Company owns minor interests in production activities as a non-operator in the United States. During the year ended December 31, 2011, the Etame, Avouma, South Tchibala and Ebouri fields produced approximately 8.1 million barrels of oil (2.3 million barrels of oil net to the Company).

Offshore Gabon

The Company�� primary source of revenue is from the Etame Production Sharing Contract related to the Etame Marin block located offshore the Republic of Gabon. VAALCO operates the Etame Marin block on behalf of a consortium of companies. As of December 31, 2010, VAALCO owned a 30.35% interest in the exploration acreage within the Etame Marin block. The Company owns a 28.1% interest in the development areas surrounding the Etame, Avouma, South Tchibala and Ebouri fields, each of which is located on the Etame Marin block. The Company produces from the Etame, Avouma, South Tchibala and Ebouri fields on the block.

Onshore Gabon

The Mutamba Iroru block is ocated onshore near the coast in central Gabon. The Mutamba Iroru block contains an exploration area of approximately 270,000 acres.

Offshore Angola

The Company has 40% working interest in Offshore Angola. The four year primary term with an optional three year extension awards the Company exploration rights to 1.4 million acres offshore central Angola.

Onshore Domestic-Texas

In July 2011, the Company acquired a 480 acre lease in the Granite Wash formation in North Texas. In November 2011, the Company commen! ced drilling a second well on the initial Granite Wash formation lease.

Onshore DomesticMontana

In May 2011, the Company acquired a 70% working interest in approximately 5,200 acres (3,640 net acres) in Sheridan County, Montana in the Middle Bakken formation. In September 2011, it acquired a 65% working interest in approximately 22,000 gross acres covering the Middle Bakken and deeper formations in the East Poplar unit and the Northwest Poplar field in Roosevelt County, Montana.

DomesticOutside Operated

The Company has minor interests in Brazos County, Texas producing from the Buda/Georgetown formations. The Company also owns certain minor non-operated interests in the Ship Shoal area of the Gulf of Mexico and in Pickens County, Alabama.

Advisors' Opinion:
  • [By Laura Brodbeck]

    Thursday

    Earnings Expected From: AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), Kirkland��, Inc (NASDAQ: KIRK), Dollar General Corporation (NYSE: DG), Stein Mart, Inc. (SMRT: NASDAQ), Mattress Firm Holding Corp. (NASDAQ: MRFM), SeaWorld Entertainment (NYSE: SEAS), Vaalco Energy Inc (NYSE: EGY) Economic Releases Expected: Chinese retail sales, French CPI, Brazilian retail sales, US retail sales, Japanese industrial production

    Friday

Top 10 Oil Companies To Invest In Right Now: Renewable Energy Group Inc (REGI)

Renewable Energy Group, Inc., incorporated in August 2006, is a producer of biodiesel in the United States. The Company is engaged in each aspect of biodiesel production, from acquiring feedstock, managing construction and operating biodiesel production facilities to marketing, selling and distributing biodiesel and its co-products. During the year ended December 31, 2011, the Company sold approximately 150 million gallons of biodiesel. As of December 31, 2011, the Company operated a network of six biodiesel plants, with an aggregate production capacity of 212 million gallons per year. On July 12, 2011, the Company acquired SoyMor Biodiesel, LLC (SoyMor), which has 30 million gallons per year biodiesel production facility in Albert Lea, Minnesota. In January 2012, it exercised its option to purchase the 60 million gallons per year facility in Seneca, Illinois, which it operated under a lease. In August 2013, the Company acquired biodiesel plant in Mason City, Iowa. In January 2014, Renewable Energy Group Inc acquired renewable chemical technology developer LS9, Inc.

The Company produces its biodiesel from a range of feedstocks, including inedible animal fat, used cooking oil and inedible corn oil. It also produces a smaller portion of its biodiesel from virgin vegetable oils. It owns biodiesel production facilities with capacities consisting of 12 million gallons per year facility in Ralston, Iowa; 35 million gallons per year facility near Houston, Texas, or the Houston facility; 45 million gallons per year facility in Danville, Illinois, and 30 million gallons per year facility in Newton, Iowa.

The Company competes with Archer Daniels Midland Company, Cargill, Incorporated, Louis Dreyfus Commodities Group, Ag Processing Inc., Mansfield, Astra, Gavilon, Tenaska, ED&F Man, Dynamic Fuels, LLC, Syntroleum Corporation, Tyson Foods, Inc., Diamond Green Diesel, LLC and Darling International.

Advisors' Opinion:
  • [By Maxx Chatsko]

    The third well-researched pick was Renewable Energy Group (NASDAQ: REGI  ) . The nation's largest biodiesel producer was a recently public company at the time and probably got caught in the punishment unleashed upon industrial biotech companies that failed to live up to their early promises. I just didn't think it was justified for REG. Biodiesel is produced in a relatively simple process. Better yet, the company was growing and poised to continue growing with capacity additions looming. Investors finally caught on after REG notched its first year with $1 billion in sales in 2012, and sent shares 120% higher in 2013.

Top 10 Oil Companies To Invest In Right Now: Cobalt International Energy Inc (CIE)

Cobalt International Energy, Inc., incorporated on August 27, 2009, independent, oil-focused exploration and production company with a salt prospect inventory in the deepwater of the United States Gulf of Mexico and offshore Angola and Gabon in West Africa. The Company operates its business in two geographic segments: the U.S. Gulf of Mexico and West Africa. The Company�� oil-focused exploration efforts target subsalt Miocene and Inboard Lower Tertiary horizons in the deepwater U.S. Gulf of Mexico. As of December 31, 2012, it drilled as operator four exploratory wells in the deepwater U.S. Gulf of Mexico (North Platte #1, Ligurian #1 and #2, and Criollo #1) and participated as a non-operator in three exploratory wells (Heidelberg #1, Shenandoah #1 and Firefox #1) and three appraisal wells (Heidelberg #2, Heidelberg #3, and Shenandoah #2R). The Company�� oil-focused exploration efforts target pre-salt horizons on Blocks 9, 20 and 21 offshore Angola and the Diaba Block offshore Gabon.

U.S. Gulf of Mexico Segment

The Company�� oil-focused exploration efforts target subsalt Miocene and Inboard Lower Tertiary horizons in the deepwater U.S. Gulf of Mexico. It also has licensed approximately 78,000 line miles (125,530 kilometers) of 2-D pre-stack depth-migrated seismic data in the deepwater U.S. Gulf of Mexico. As of December 31, 2012, it owned working interests in 246 blocks within the deepwater U.S. Gulf of Mexico, representing approximately 1.4 million gross (0.7 million net) undeveloped acres. Most of its U.S. Gulf of Mexico blocks have a 10-year primary term.

The Ardennes #1 exploratory well will target a 3-way structure located in both Miocene and Inboard Lower Tertiary horizons located in Green Canyon blocks 895, 896 and 939, where it named operator and owns a 42% working interest. The Aegean #1 exploratory well will target a 3-way structure in Inboard Lower Tertiary horizons located in Keathley Canyon blocks 162, 163 and 207, where it named operator and ow! n a 37.5% working interest. It has 24% working interest in the Racer prospect and its partners include BHP Billiton Petroleum (Americas) Inc. (60%) and Total (16%). South Platte is a 3-way prospect targeting Inboard Lower Tertiary horizons located in Garden Banks blocks 1003 and 1004 and Keathley Canyon blocks 35 and 36, and owns 60% working interest. Its Baffin Bay is a 4-way prospect targeting Inboard Lower Tertiary horizons located in Garden Banks blocks 956 and 957, and owns 60% working interest.

The Company has one drilling rig, the Ensco 8503, that is performing drilling operations on its operated prospect portfolio in the deepwater U.S. Gulf of Mexico. It has one drilling rig, the Ensco 8503, that is performing drilling operations on its operated prospect portfolio in the deepwater U.S. Gulf of Mexico. On December 5, 2012, it announced an oil discovery at its North Platte prospect on Garden Banks block 959 in the deepwater U.S. Gulf of Mexico. The North Platte #1 exploratory well is located in approximately 4,400 feet of water and was drilled to a total depth of approximately 34,500 feet. It is a operator of North Platte and own a 60% working interest. Its Heidelberg #1 exploratory well is located in approximately 5,200 feet of water in Green Canyon block 859 within the Tahiti Basin Miocene trend. The Company�� Shenandoah #1 is located in approximately 5,750 feet of water in Walker Ridge block 52, was drilled to approximately 30,000 feet. On February 26, 2013, it announced that the Shenandoah #2R appraisal well had been drilled to a total depth of 31,400 feet in approximately 5,800 feet of water and 1.3 miles southwest of the Shenandoah #1 exploratory well.

West Africa Segment

As of December 31, 2012, the Company had drilled as operator one exploratory well on Block 21 offshore Angola (Cameia #1) and one appraisal well on Block 21 offshore Angola (Cameia #2). As of December 31, 2012, its working interests in Blocks 9, 20 and 21 offshore Angola and the Diab! a Block o! ffshore Gabon consisted of an aggregate 5,652,687 gross (1,840,581 net) undeveloped acres. It has a pre-salt prospect inventory offshore West Africa. This inventory includes dozens of prospects in various states of maturation on Blocks 9, 20 and 21 offshore Angola and the Diaba Block offshore Gabon. The Mavinga #1 exploratory well will target pre-salt horizons in Block 21 offshore Angola, where it named operator with a 40% working interest. The Lontra #1 exploratory well will target pre-salt horizons in Block 20, and owns 40% working interest. The Bicuar #1 exploratory well will target pre-salt horizons in Block 21 offshore Angola, and owns 40% working interest. The Idared #1 exploratory well will target pre-salt horizons in Block 20 offshore Angola. The Baleia #1 exploratory well will target pre-salt horizons in Block 20 offshore Angola, and owns 40% working interest. The Loengo #1 exploratory well will target pre-salt horizons in Block 9 offshore Angola. Its Diaman #1 exploratory well owns 21.25% working interest. Its Diamon South #1 exploratory well will test pre-salt horizons on the Diaba block offshore Gabon, where Total Gabon is the named operator and we own a 21.25% working interest. The Company has two drilling rigs under contract to support its pre-salt exploratory drilling campaign offshore Angola: the Diamond Ocean Confidence and the Petroserv SSV Catarina. It has the right to use the Ocean Confidence to complete the DST on the lower reservoir penetrated by the Cameia #2 appraisal well and drill two additional wells, which will include its Mavinga #1 exploratory well and one additional well.

Advisors' Opinion:
  • [By Paul Ausick]

    Cobalt International Energy Inc. (NYSE: CIE) is down 14.3% at $25.18. The independent oil & gas company reported a dry hole in one of its Gulf of Mexico wells.

  • [By Jayson Derrick]

    Cobalt Energy (NYSE: CIE) provided an update on its Gulf of Mexico drilling operations. The company announced that its Aegean #1 exploratory well in Keathley Canyon Block 163 did not encounter commercial hydrocarbons and operations are underway to plug and abandon the wellbore. Shares hit new 52 week lows of $13.75 before closing at $14.84, down 5.24 percent.

  • [By Aaron Levitt]

    Offering both promise and fortune, Africa is certainly one of the last frontiers in investing. But it can be a pretty cruel mistress as well. Investors in independent oil and gas producer Cobalt International Energy, (CIE) are finding that out the hard way.

Top 10 Oil Companies To Invest In Right Now: Forum Energy Technologies Inc (FET)

Forum Energy Technologies, Inc. incorporated on May 10, 2005, is an oilfield products company, serving the subsea, drilling, completion, production and infrastructure sectors of the oil and natural gas industry. The Company designs and manufactures products, and engage in aftermarket services, parts supply and related services that complement its product offering. It operates in two segments: Drilling and Subsea Segment and Production and Infrastructure Segment. In December 2012, the Company acquired Merrimac Manufacturing, Inc. (Merrimac). In May 2013, the Company acquired Blohm + Voss Oil Tools from STAR Capital Partners Limited. In July 2013, Forum Energy Technologies Inc acquired Moffat 2000 Ltd.

Drilling and Subsea Segment

The Company designs and manufactures products and provides related services to the drilling, well construction, completion, intervention and subsea construction and services markets. Through this segment, it offers Subsea Technologies, including robotic vehicles and other capital equipment, specialty components and tooling, a range of complementary subsea technical services and rental items, and applied products for subsea pipelines. It offers Drilling Technologies which include capital equipment and a range of products consumed in the drilling and well intervention process. It offers Downhole Technologies, including cementing and casing tools, completion products, and a range of downhole protection solutions.

The Company designs and manufactures subsea capital equipment; specialty components and tooling; and applied products for subsea pipelines; and it also provides a suite of complementary subsea technical services and rental items. It has a core focus on the design and manufacture of unmanned submarines, remotely operated vehicles (ROVs), as well as other specialty subsea vehicles. The Company�� brands include its Perry and Sub-Atlantic vehicle brands. Its related technical services complement its vehicle offering by providing the m! arket with a selection of critical product solutions and rental items that enhance its customers��ability to operate in harsh subsea environments. The market for subsea ROVs can be segmented into three classes of vehicles based on size and category of operations: large work-class vehicles for subsea construction activities; drilling-class vehicles for use around an offshore rig, and observation-class vehicles for inspection and light manipulation. The Company is a provider of work-class and observation-class vehicles.

The Company manufactures ROV components, such as a range of Sub-Atlantic branded ROV thrusters. It designs and manufactures thrusters for incorporation into its own vehicles, as well for sale to other ROV manufacturers. It also designs and manufactures a tether management system (TMS). It also provides a suite of subsea tooling, both industry standard and custom designed for subsea applications. Industry standard tooling includes hot stabs, cable cutters, torque tools and indicators.

The vehicle-related subsea products, its Offshore Joint Services (OJS) brand is a provider of applied protective coatings on rigid subsea pipeline field joints, spools, and structures. Its VisualSoft product line provides another related technical product that reinforces in subsea vehicles and products. It sells or rents VisualWorks and VisualDVR Digital Video Systems that provide a solution for digital video capture, playback, processing and reporting of pipeline, structural or other inspection survey data. These products are often used in conjunction with the operation of inspection class ROVs or diving personnel when conducting survey work.

Geoscience Earth and Marine Science (GEMS) is its geophysical and geotechnical engineering group that provides consulting services to the oil and gas, and marine industries. It provides an interpretation service based on the analysis of third party subsea data provided by clients. The business has broadened into managing every p! hase of p! roject development, including scope of work, liaising with data acquirers, interpretation and analysis. Its primary customer base consists of oil and gas operator producers.

The Company provides both drilling consumables and capital equipment, including powered and manual tubular handling equipment, specialized torque equipment, customized offline crane systems, drilling data acquisition management systems, pumps, valves, manifolds, drilling fluid-end components, pressure control equipment for both coiled tubing and wireline well intervention operations and a broad line of items consumed in the drilling process. The Company has a core focus on products that enhance its customers��handling of tubulars on the drilling rig.

The Company designs and manufactures specialized torque equipment and related control systems for tubular connections, including high torque stroking, or bucking, units, fully rotational torque units, portable torque units for field deployment. In addition the Company designs and manufactures a range of rig-based offline activity cranes, multi-purpose cranes and personnel transfer solutions.

The Company�� pressure control products used for well intervention operations are sold directly to oilfield service companies and equipment rental companies. These products include both coiled tubing and wireline blowout preventers and their accessories. It also conduct aftermarket refurbishment and recertification services for pressure control equipment. The Company also designs and manufactures a range of consumable parts for pumps on drilling rigs, well servicing rigs, pressure pumping units, and hydraulic fracturing systems, along with top drive parts. The Company also manufacture data acquisition products that include integrated drill floor instrumentation and monitoring systems. These systems provide real-time monitoring and logging of drilling data to drilling contractors and oil and gas producers on the rig and at remote locations.

! The Compa! ny manufacture a broad line of downhole products that are consumed during the well construction, completion and production enhancement process. Through its Davis-Lynch downhole well construction and completion tools product line, it designs and manufactures products used in the construction of oil and gas wells. It designs and manufactures a range of centralizers, float equipment, stage cementing tools, inflatable packers, flotation collars, cementing plugs, fill and circulation tools for running casing, casing hangers and surge reduction equipment.

The Company manufactures a line of downhole completion tools, including composite plugs and wireline flow-control products. Its composite plugs are primarily used for zonal isolation during multi-stage hydraulic fracturing in horizontal and vertical wells. It offers l range of downhole protection solutions.

Production and Infrastructure Segment

The Company designs and manufactures products and provide related equipment and services to the well stimulation, completion, production and infrastructure markets. Through this segment, the Company suppllies Flow Equipment, including well stimulation consumable products and related recertification and refurbishment services; Production Equipment, including well site production equipment, process equipment and specialty pipeline construction equipment; and Valve Solutions, which includes a range of industrial and process valves.

The Company provides a range of high pressure flow equipment used by well stimulation, or pressure pumping, companies during the stimulation, intervention and flowback process. It focuses on consumable products that experience high rates of wear and replacement. The Company designs and manufactures pressure control plug, choke and relief valves, swivel joints, pup joints and integral fittings, manifolds and manifold trailers, as well as triplex and quintuplex fluid-end assemblies.

The Company surface Production Equipment product line p! rovides e! ngineered process systems and field services for capital equipment used at the wellsite, for production processing, and at the refinery. It serves the upstream, midstream and downstream segments in oil and gas production equipment and services. The Company engineers fabricates and installs tanks, separators, packaged production systems and American Society of Mechanical Engineers (ASME) and American Petroleum Institute (API) coded and non-coded pressure vessels, skidded vessels with gas measurement, modular process plants, header and manifold skids, process and flow control equipment and separators to help clean and process oil or gas as it travels from the wellhead and along the transmission line to the refinery.

The Company design, manufacture and provide a wide range of industrial valves that principally serve the upstream, midstream and downstream markets of the oil and gas industry. In addition its valve solutions serve general industrial, power and process industry customers as well as the mining industry. It also provides ball, gate, globe, check and butterfly valves across a range of sizes and applications.

The Company competes with Cameron International Corporation and FMC Technologies, Inc.

Advisors' Opinion:
  • [By Dan Caplinger]

    Another issue that Varco has to face is the specter of increasing competition. Cameron International (NYSE: CAM  ) has arisen as a big player in the drilling and production systems space, with a particular emphasis on subsea applications like blowout preventers. With Cameron sporting a recent partnership with Schlumberger (NYSE: SLB  ) , the combination will have both the expertise and the financial resources to challenge Varco in that niche. More broadly, up-and-coming Forum Energy (NYSE: FET  ) has sought to emulate Varco's broad-based services menu, offering remotely operated vehicles for deepwater inspection and construction as well as pipe and cementing materials and a range of subsea systems and equipment. Forum has posted solid results in its brief history, taking steps to continue its fast growth trajectory.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Forum Energy Technologies (NYSE: FET  ) , whose recent revenue and earnings are plotted below.

Top 10 Oil Companies To Invest In Right Now: 1st NRG Corp (FNRC)

1st NRG Corp., incorporated on January 18, 1988, is an exploration and production company. The Company is engaged in the development of the Clabaugh Ranch Field, which is a project developing and producing coal bed methane reserves (CBM). This project includes a development of 6,025 gross acres in the Powder River Basin in northeast Wyoming. The Company is expanding its activities into unconventional shale through a participation agreement covering approximately 7,000 acres initially and subsequently acquired acreage covering an Area of Mutual Interest in South Eastern Ohio. Its production revenues are entirely from the natural gas produced at Clabaugh Ranch.

The targeted coal seams in the Powder River Basin are part of the Tongue River Member of the Fort Union formation and have been mapped as natural resource developments and exploration have occurred throughout the region. The Company has 42 drilled wells, which have encountered developed coal seams in the Werner, Upper and Lower Smith, Wyodak/Anderson Lower, Gates and Wall formations. In total the Company has identified 515 separate coals seams for development of which only 126 (42 wells X 3 seams) have been completed.

Advisors' Opinion:
  • [By Peter Graham]

    What�� the Catch With Quantum Energy Inc? According to various disclosures, transactions of $2k and $3.5k have or will occur to mention Quantum Energy in various investment newsletters. On Friday, Quantum Energy released the pricing of its recently announced $5,000,000 BDC funding to be arranged by Data Capital Corp (DCC) where the latter has agreed to assist the former in the formation of a Business Development Company (BDC) by forming Quantum Funding, Inc. as a BDC to raise an initial $5,000,000. Upon receipt of the funding, Quantum Funding, Inc. will then be acquired as a subsidiary by QEGY in a share exchange where the $5,000,000 subsidiary will be acquired for 10,000,000 shares of newly issued restricted common stock for a valuation of $0.50 cents per share. Otherwise and early in the month, Quantum Energy announced it was shifting its focus from the West Texas Barnett Shale fields to North Dakota with the opening of an office in Williston, North Dakota. However, a quick look on Google Finance (as there are no up to date financials on Yahoo! Finance) reveals Quantum Energy has no revenues; a net loss of $0.01M (most recent reported quarter), net income of $2.01M and a net loss of $0.02M for the past three fiscal quarters; and $0.01M in cash to cover $0.34M in current liabilities at the end of last August. Then again, the recent financing deal could get things moving for Quantum Energy next year.

    1st NRG Corp (OTCMKTS: FNRC) Gives a Drilling and Production Update

    Small cap 1st NRG Corp is an exploration and production company currently developing and producing coal bed methane reserves (CBM) in Wyoming. On Friday, 1st NRG Corp fell 25% to $0.0003 for a market cap of $5.02 million plus FNRC is down 97.1% since the start of the year and down 99.8% since July 2010 according to Google Finance.